Merus N.V. (MRUS) Expected to Post Quarterly Sales of $2.59 Million

Wall Street analysts expect Merus N.V. (NASDAQ:MRUS) to announce $2.59 million in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Merus N.V.’s earnings. The lowest sales estimate is $1.94 million and the highest is $3.23 million. Merus N.V. reported sales of $1.24 million in the same quarter last year, which indicates a positive year-over-year growth rate of 108.9%. The business is expected to announce its next earnings report on Monday, August 14th.

On average, analysts expect that Merus N.V. will report full year sales of $2.59 million for the current financial year, with estimates ranging from $8.58 million to $11.04 million. For the next fiscal year, analysts expect that the company will report sales of $17.13 million per share, with estimates ranging from $7.89 million to $26.37 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Merus N.V..

Several equities research analysts recently weighed in on MRUS shares. Jefferies Group LLC reaffirmed a “buy” rating and set a $33.00 price target on shares of Merus N.V. in a report on Wednesday, April 26th. Zacks Investment Research downgraded Merus N.V. from a “hold” rating to a “sell” rating in a report on Friday, May 5th. ValuEngine upgraded Merus N.V. from a “sell” rating to a “hold” rating in a research report on Saturday, May 20th. Finally, Wedbush reiterated an “outperform” rating and issued a $32.00 price objective on shares of Merus N.V. in a research report on Tuesday, June 6th. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have given a buy rating to the company’s stock. Merus N.V. has an average rating of “Hold” and a consensus price target of $26.00.

Shares of Merus N.V. (MRUS) opened at 16.37 on Tuesday. The stock’s market cap is $317.43 million. Merus N.V. has a one year low of $8.42 and a one year high of $33.63. The company has a 50-day moving average of $16.20 and a 200 day moving average of $21.34.

TRADEMARK VIOLATION WARNING: This piece was originally posted by Community Financial News and is owned by of Community Financial News. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.com-unik.info/2017/08/19/merus-n-v-mrus-expected-to-post-quarterly-sales-of-2-59-million-updated-updated.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Spark Investment Management LLC purchased a new position in shares of Merus N.V. during the first quarter worth $458,000. Renaissance Technologies LLC purchased a new position in shares of Merus N.V. during the first quarter worth $549,000. Norges Bank purchased a new position in shares of Merus N.V. during the fourth quarter worth $790,000. Victory Capital Management Inc. purchased a new position in shares of Merus N.V. during the first quarter worth $976,000. Finally, Iguana Healthcare Management LLC boosted its position in shares of Merus N.V. by 16.7% in the first quarter. Iguana Healthcare Management LLC now owns 175,000 shares of the biotechnology company’s stock worth $4,268,000 after buying an additional 25,000 shares in the last quarter. Institutional investors and hedge funds own 32.59% of the company’s stock.

Merus N.V. Company Profile

Get a free copy of the Zacks research report on Merus N.V. (MRUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merus N.V. (NASDAQ:MRUS)

What are top analysts saying about Merus N.V.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merus N.V. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit